[Greenlight laser vaporization: Past, present and future?]

Area of Science:

• Urology
• Minimally Invasive Surgery
• Laser Technology

Background:

• Benign prostatic hyperplasia (BPH) causes lower urinary tract symptoms (LUTS).
• Transurethral prostate resection (TURP) is a traditional surgical option.
• Greenlight laser vaporization presents a modern alternative for BPH treatment.

Purpose of the Study:

• To review current evidence on Greenlight laser vaporization for BPH.
• To evaluate its efficacy, safety, and economic impact compared to TURP.
• To discuss technological advancements and clinical considerations.

Main Methods:

• Review of clinical trial data, including the Goliath trial.
• Analysis of functional outcomes, complication rates, and hospital stay duration.
• Assessment of cost-effectiveness and technological evolution.

Main Results:

• Greenlight 180W vaporization demonstrated non-inferiority to TURP with similar mid-term outcomes.
• Shorter hospital stays and comparable complication rates were observed.
• Higher potency laser generators enable shorter operative times and same-day discharge, with low readmission rates.

Conclusions:

• Greenlight laser vaporization is a cost-effective and viable alternative to TURP.
• Technological advancements continue to enhance its clinical utility.
• It remains a valuable option for managing LUTS due to BPH.